INDIANAPOLIS, June 26 /PRNewswire/ -- Polymer Technology Systems, Inc.,
has introduced the BioScanner 2000(TM), the first comprehensive personal
health monitor for people with diabetes. In addition to measuring blood
glucose, the patented analyzer allows users to track their total cholesterol,
HDL cholesterol and ketone levels, eliminating special trips to the
physician's office for cholesterol workups as well as separate urine ketone
tests. Additional tests for triglycerides, LDL cholesterol and other
variables are in various stages of development or FDA review.
The device's ability to measure multiple blood chemistries is unique among
home testers, offering a one-stop solution to aid diabetes patients in
managing their disease as well as its complications. The BioScanner 2000 is
also a useful tool for physicians because test results are returned in
approximately one minute, permitting immediate feedback while patients are in
the doctor's office. The unit is roughly the size of a small calculator,
utilizes different test strips for different tests, and permits one-step
testing without a blood wipe.
"Most diabetes patients don't die of diabetes; they suffer from
complications such as kidney disease and heart disease. Our goal is to help
people maintain control by allowing them to monitor themselves easily at
home," said Scott Housefield, President of Polymer Technology Systems. "By
enabling diabetes patients to do their own blood cholesterol screening and
overcoming the shortcomings of urine-based ketone tests, we are equipping them
with the tools to manage their disease better than ever before."
Like a conventional glucose meter, the BioScanner 2000 operates by gauging
the intensity of the color on a test strip and converting that color to a
blood chemistry measurement. Instead of having one optical reader inside to
do the work, however, the BioScanner 2000 has three, each with five different
LEDs that can interpret different tests.
The user simply selects the test strip designed for the specific test,
inserts a special postage stamp-sized calibration chip in a slot on the side
of the analyzer, and pricks his or her finger. The chip tells the device
which test it is performing, and the unit automatically displays the relevant
Because switching from one test to another requires nothing more than
different test strips and calibration chips, the number of tests that can be
performed with the BioScanner 2000 can be expanded without changing the
testing unit -- a technological first for an in-home analyzer.
The four tests currently available have received FDA clearance for both
consumer and professional use. The total cholesterol and HDL ("good")
cholesterol tests are aimed at minimizing the risk of heart attack because
individuals with diabetes are up to four times as likely to develop heart
disease as the non-diabetic population. The ketone test is designed to detect
a significant concentration of ketones that can lead to kidney damage, coma or
diabetic ketoacidosis, a potentially fatal condition caused by low insulin
levels or insufficient metabolization of glucose.
A fifth test for triglyceride levels has received FDA clearance for
professional use and is awaiting review for consumer use.
The BioScanner 2000 allows users to apply blood to a test strip either
before or after inserting it into the meter, making it easy to handle for
those with dexterity problems. It calculates 10-test, 14-day or 30-day
averages; stores up to 700 test results; and automatically shuts off after two
minutes of idle time.
The BioScanner 2000 was introduced in Indianapolis in April and is
currently being rolled out nationally. Select Wal-Mart stores will begin
carrying the product in mid-June. The unit retails for $199.95. Test strips
range from 55 cents to $2.75 per strip for current tests. For more
information, call toll-free at 877-870-5610 or visit www.diabetes-testing.com
on the Web.
CONTACT: Angi Taylor of S&S Public Relations, 317-722-3500, ext. 25, or
email@example.com, for Polymer Technology Systems, Inc.
SOURCE Polymer Technology Systems, Inc.